feed,title,long_url,short_url
MarketWatch,Eli Lilly and UnitedHealth to study Lilly's antibody treatment bamlanivimab in high-risk COVID patients,http://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/ppRMcbiLQD0/story.aspx,https://on.mktw.net/3oiYbh2
